Last reviewed · How we verify
Juvenile rheumatoid arthritis
Approved treatments
- Aurolate
- Celebrex · Pfizer Inc. (originally Searle/Pharmacia)
Celecoxib works by inhibiting COX-2 to reduce prostaglandin synthesis, thereby decreasing pain, inflammation, and fever. - DEXIBUPROFEN
- Cortone
- Aureotan
- prednison · Wen Zhang
- Azulfidine En-Tabs · Pfizer
- Medrol · Generic (originally Upjohn/Pfizer)
Potent synthetic glucocorticoid with 5x hydrocortisone potency and minimal mineralocorticoid activity, used for severe inflammatory conditions. - Rodinolone
- Deltasone · Generic (originally Schering)
- Lithobid · Generic (multiple manufacturers)
- Advil · Generic (originally Boots Group)
Ibuprofen inhibits prostaglandin synthetase, reducing pain, fever, and inflammation. - Lithium Carbonate
- Daypro · Solubiomix
- Lodine · Pfizer
- Azulfidine En-Tabs · Pfizer
Anti-inflammatory and immunomodulatory properties with affinity for connective tissue and high concentration in serous fluids. - Roactemra · Roche
Roactemra works by blocking the interleukin-6 receptor, a protein that plays a key role in inflammation. - Tolectin 600
- Betametasone
Betamethasone works by binding to the glucocorticoid receptor, which then triggers a series of downstream effects that reduce inflammation and suppress the immune system. - Mobic · Boehringer Ingelheim
Meloxicam works by inhibiting the enzyme prostaglandin G/H synthase 2, which is involved in the production of prostaglandins that cause pain and inflammation. - Trexall · Generic (originally Lederle Laboratories)
Antifolate that inhibits dihydrofolate reductase (DHFR), blocking DNA synthesis at high doses (oncology) and suppressing inflammation at low doses (autoimmune). - Methotrexat · Biocad
- Prelone · Generic (originally Schering)
- celebrex · POZEN
- prednisolon · Hannover Medical School
- Vioxx · M.D. Anderson Cancer Center
- Methylprednisolon · Leiden University Medical Center
- Aleve · Generic (originally Syntex)
Reversibly inhibits COX-1 and COX-2 with a long half-life, providing sustained anti-inflammatory, analgesic, and antipyretic effects.
Clinical guidelines
- FDA label — 1L|2L
Sulfasalazine is indicated for the treatment of juvenile rheumatoid arthritis. - FDA label — 1L
For relief of the signs and symptoms of juvenile rheumatoid arthritis
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Juvenile rheumatoid arthritis patent landscape — cliff calendar, originator estates, attackable patents
- Juvenile rheumatoid arthritis treatment landscape brief
- Juvenile rheumatoid arthritis treatment updates RSS
Frequently asked questions about Juvenile rheumatoid arthritis
What drugs treat Juvenile rheumatoid arthritis?
Tracked treatments include Aurolate, Celebrex, DEXIBUPROFEN, Cortone, Aureotan, prednison, Azulfidine En-Tabs, Medrol.
What is the treatment for Juvenile rheumatoid arthritis?
Standard treatment for Juvenile rheumatoid arthritis includes Aurolate, Celebrex, DEXIBUPROFEN, Cortone, Aureotan. See the treatment landscape page for first-line, second-line and salvage options.
What are the treatment guidelines for Juvenile rheumatoid arthritis?
FDA label publishes guidelines for Juvenile rheumatoid arthritis. 2 guideline references tracked.
Related
- Treatment landscape: Juvenile rheumatoid arthritis patent cliff · Juvenile rheumatoid arthritis CI report
- Treatment: Aurolate
- Treatment: Celebrex · Pfizer Inc. (originally Searle/Pharmacia)
- Treatment: DEXIBUPROFEN
- Treatment: Cortone
- Treatment: Aureotan
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing